Scientific paper - Review paper
Farmakoterapija šećerne bolesti tipa 2
Farmaceutski glasnik, 75 (2019), 9; 629-664. urn:nbn:hr:163:607971

Cvek, Josipa; Mirošević Skvrce, Nikica; Vučić, Katarina; Andrić, Adriana; Ortner Hadžiabdić, Maja

Cite this document

Cvek, J., Mirošević Skvrce, N., Vučić, K., Andrić, A. & Ortner Hadžiabdić, M. (2019). Farmakoterapija šećerne bolesti tipa 2. Farmaceutski glasnik, 75. (9), 629-664. Retrieved from https://urn.nsk.hr/urn:nbn:hr:163:607971

Cvek, Josipa, et al. "Farmakoterapija šećerne bolesti tipa 2." Farmaceutski glasnik, vol. 75, no. 9, 2019, pp. 629-664. https://urn.nsk.hr/urn:nbn:hr:163:607971

Cvek, Josipa, Nikica Mirošević Skvrce, Katarina Vučić, Adriana Andrić and Maja Ortner Hadžiabdić. "Farmakoterapija šećerne bolesti tipa 2." Farmaceutski glasnik 75, no. 9 (2019): 629-664. https://urn.nsk.hr/urn:nbn:hr:163:607971

Cvek, J., et al. (2019) 'Farmakoterapija šećerne bolesti tipa 2', Farmaceutski glasnik, 75(9), pp. 629-664. Available at: https://urn.nsk.hr/urn:nbn:hr:163:607971 (Accessed 10 October 2024)

Cvek J, Mirošević Skvrce N, Vučić K, Andrić A, Ortner Hadžiabdić M. Farmakoterapija šećerne bolesti tipa 2. Farmaceutski glasnik [Internet]. 2019 [cited 2024 October 10];75(9):629-664. Available at: https://urn.nsk.hr/urn:nbn:hr:163:607971

J. Cvek, N. Mirošević Skvrce, K. Vučić, A. Andrić and M. Ortner Hadžiabdić, "Farmakoterapija šećerne bolesti tipa 2", Farmaceutski glasnik, vol. 75, no. 9, pp. 629-664, 2019. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:163:607971. [Accessed: 10 October 2024]

Please login to the repository to save this object to your list.